Skip to main content

Seattle Biomedical Research Institute Lands $30.6M to Establish Structural Genomics Center

NEW YORK (GenomeWeb News) – The Seattle Biomedical Research Institute will use a $30.6 million contract award from the National Institute for Allergy and Infectious Diseases to run a collaborative initiative aimed at using genomics and translational research methods to study a number of diseases, the institute said recently.
SBRI will use the five-year contract to start the Seattle Structural Genomics Center for Infectious Disease, and it will work with researchers at the University of Washington, Battelle Northwest, and Decode Biostructures, which is a subsidiary of Decode Genetics.
The goal of the center is to determine the three-dimensional structures of proteins from bacterial, viral, fungal, and protozoan pathogens that cause emerging and re-emerging infectious diseases, SBRI said, in order to develop a “blueprint” to be used in development of new drug treatments.
“By determining the three-dimensional structure of these proteins, we can identify important pockets or clefts and design small molecules which will disrupt their disease-causing function,” SBRI Principal Investigator Peter Myler said in a statement.
Myler aims for the center to solve 75 to 100 protein structures per year, with the results of the research being published and shared with scientists around the world.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.